Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

• • May 19, 2009
  • AstraZeneca statement on confirmation of FDA Commissioner  
• • May 18, 2009
  • AstraZeneca announces TOPROL-XL® (metoprolol succinate) is now available  
• • May 15, 2009
  • Strength and diversity of AstraZeneca oncology portfolio highlighted at ASCO  
• • May 7, 2009
  • AstraZeneca statement on FDA funding  
• • May 7, 2009
  • AstraZeneca CEO calls for health care reform  
• • May 4, 2009
  • AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product  
• • Apr 30, 2009
  • AstraZeneca PLC first quarter results 2009  
• • Apr 28, 2009
  • AstraZeneca applauds confirmation of new HHS Secretary  
• • Apr 28, 2009
  • Area charity care programs get timely boost during Delaware’s “Cover the Uninsured Month”  
• • Apr 21, 2009
  • AstraZeneca supports PhRMA, Families USA partnership to promote quality, affordable healthcare coverage  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed